Many patients receive treatment through medication. The treatments are especially useful for patients who are at the maximum dosage of other heart drugs, people awaiting a heart transplant, or people who have a heart muscle disease. The treatment also helps patients breathe more easily.
Quick Facts about the WVU Medicine Advanced Heart Failure Program
- Provides IV inotropic therapy to stable outpatients with advanced heart failure, with a goal of improving functional level and avoiding hospitalization
- One of 16 national sites of excellence to offer the CardioMEMS™ HF system, the first and only FDA-approved heart failure (HF) monitoring system proven to significantly reduce HF hospital admissions and improve quality of life in NYHA class Ill patients
CardioMEMS HF System
It is estimated that patients who monitor their congestive heart failure with the CardioMEMS system may reduce their risk for sudden hospital readmission by almost 37 percent. We are designated as one of 16 national sites of excellence by the device manufacturer, and we are the only site in West Virginia currently offering this procedure. WVU Heart and Vascular Institute physicians are proud to be able to offer this technology to our patients.
Another option for the intractable angina patient who fails to respond to conventional treatment is a non-invasive technique called enhanced external counterpulsation (EECP). This therapy involves placing blood pressure cuffs on the lower extremities to force blood from the heart into the vessels.